Recent Quotes
My Watchlist
Indicators
Hydroworld Market Index
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Neuronetics, Inc. - Common Stock (NQ:STIM)

1.380 -0.050 (-3.50%)
Streaming Delayed Price Updated: 4:00 PM EST, Feb 18, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Neuronetics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >
News headline image
Expanded Health Policies Enhance TMS Therapy Access for Adolescents and Adults
BlueCross BlueShield of North Carolina and Louisiana Medicaid Increase Coverage for Patients with Depression 
From Neuronetics
Via GlobeNewswire
News headline image
NeuroStar® Releases Software Upgrades to Elevate Patient Care
Upgrades improve communication, streamline data management, and strengthen security 
From Neuronetics
Via GlobeNewswire
News headline image
Retractable Technologies And 2 Other Penny Stocks Executives Are Buying ↗
 
Via Benzinga
News headline image
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Enstar Group Limited (Nasdaq – ESGR), PetIQ, Inc. (Nasdaq – PETQ), Greenbrook TMS, Inc. (OTC – GBNHF), GSE Solutions, Inc. (Nasdaq – GVP)
From Brodsky & Smith LLC
Via GlobeNewswire
News headline image
NeuroStar Honors Suicide Prevention Month With Milestone Achievement and Powerful Stories
NeuroStar Is More Than Halfway to Achieving Its Five-Year Goal of Saving Thousands of Lives 
From Neuronetics
Via GlobeNewswire
News headline image
Butterfly Network And 3 Other Stocks Under $2 Executives Are Aggressively Buying ↗
 
Via Benzinga
News headline image
NeuroStar® Marks Two Years of Transformative Impact with NeuroStar University
Celebrating milestones in patient care and practice enhancement through NeuroStar’s innovative training facility 
From Neuronetics
Via GlobeNewswire
News headline image
Gold Gains Over 1%; Starbucks Shares Move Higher ↗
 
Via Benzinga
News headline image
Noninvasive Treatment Provider Neuronetics Agrees To Merge With Canadian Firm Greenbrook TMS; Reports Q2 Earnings And Guidance Below Expectations ↗
Neuronetics to acquire Greenbrook TMS (OTC: GBNHF) in an all-stock deal, doubling revenue to $145M. The combined company expects mid-teens growth in 2025 and 2026, with $15M in cost savings and... 
Via Benzinga
News headline image
Crude Oil Surges 2%; B. Riley Financial Shares Plunge ↗
 
Via Benzinga
News headline image
STIM Stock Earnings: Neuronetics Misses EPS, Misses Revenue for Q2 2024 ↗
STIM stock results show that Neuronetics missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
News headline image
Dow Dips 150 Points; Monday.com Posts Upbeat Earnings ↗
 
Via Benzinga
Topics Stocks
News headline image
NeuroStar Partners With This Is My Brave to Recognize Teen Mental Health Month
New initiative aims to provide information and resources for teen mental health amidst rising public health concerns 
From Neuronetics
Via GlobeNewswire
News headline image
Aetna Policy Update Expands TMS Availability for Adolescents With Depression
Coverage criteria consistent with recent FDA clearance for NeuroStar TMS 
From Neuronetics
Via GlobeNewswire
News headline image
3 Neurotech Stocks Bridging Mind and Machine ↗
These neurotech stocks stand at the cutting edge of healthcare, but early entrants in new fields tend to be long-term winners. 
Via InvestorPlace
News headline image
California Medicaid Adds TMS Access for 14.8 Million Adolescents and Adults
NeuroStar, the first and only TMS treatment cleared for adolescents, now covered by Medi-Cal 
From Neuronetics
Via GlobeNewswire
News headline image
BlueCross BlueShield MI and Cambia Health Solutions Expand TMS Access for Depressed Adolescents
Updated criteria post-FDA clearance for NeuroStar TMS benefit youth mental health 
From Neuronetics
Via GlobeNewswire
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday ↗
Pre-market stock movers are worth checking out on Wednesday as we break down all of the biggest news worth reading this morning! 
Via InvestorPlace
News headline image
NeuroStar® Launches Better Me Provider Program Nationwide
The first and only TMS company to establish comprehensive standards for patient care and responsiveness in the mental health industry 
From Neuronetics
Via GlobeNewswire
News headline image
NeuroStar Showcases Cutting-Edge Research at Clinical TMS Society Annual Meeting
Early prediction of nonresponse abstract selected for oral presentation as a prestigious Top 4 Abstract at CTMSS 2024 
From Neuronetics
Via GlobeNewswire
News headline image
Neuronetics And 3 Other Stocks Under $3 Insiders Are Buying ↗
 
Via Benzinga
News headline image
Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents
Policy change comes quickly after FDA clearance for NeuroStar TMS use in ages 15 and older 
From Neuronetics
Via GlobeNewswire
News headline image
Nasdaq Moves Lower; Great Lakes Dredge & Dock Shares Surge Following Upbeat Earnings ↗
 
Via Benzinga
News headline image
Why Beyond Shares Are Trading Lower By Over 20%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗
 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Tuesday's Intraday Session ↗
 
Via Benzinga
News headline image
Crude Oil Edges Lower; UBS Shares Jump After Q1 Earnings ↗
 
Via Benzinga
News headline image
STIM Stock Earnings: Neuronetics Beats EPS, Beats Revenue for Q1 2024 ↗
STIM stock results show that Neuronetics beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
News headline image
NeuroStar® TMS Advances Treatment for Adolescents During Mental Health Awareness Month
The Company is highlighting stories from adolescents with major depressive disorder on the heels of groundbreaking FDA clearance 
From Neuronetics
Via GlobeNewswire
News headline image
New Publication in Brain Stimulation Confirms Full TMS Treatment Course Is Vital
Lack of early symptom improvement is not predictive of final responder status 
From Neuronetics
Via GlobeNewswire
News headline image
Top 5 Health Care Stocks That May Plunge In March ↗
As of March 28, 2024, five stocks in the health care sector could be flashing a real warning to investors who value momentum as a key criteria in their trading decisions. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.